相关实验视频

Updated: Jul 17, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

6.0K

通过高通量测序和药物基因组学分析的综合景观,准ORMDL2在质母细胞瘤中

Fitria Sari Wulandari1,2, Chih-Yang Wang1,3,4, Sachin Kumar1,5

  • 1Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.

International journal of medical sciences
|October 6, 2025
PubMed
概括

骨样蛋白2 (ORMDL2) 在质母细胞瘤中升高,促进免疫抑制和抗癌疗法的抵抗力. 准ORMDL2可能为这种侵袭性脑瘤提供新的治疗策略.

关键词:
药物发现 药物发现 药物发现质母细胞瘤 (glioblastoma) 是一个多omics分析分析多omics分析这就是ORMDL2的意思.瘤微环境 (TME) 是指瘤的微环境.

更多相关视频

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion09:09

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion

Published on: April 12, 2020

7.4K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.6K

相关概念视频

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...